Robert Bowdring

2019 - INVO Bioscience

In 2019, Robert Bowdring earned a total compensation of $365.9K as Former Chief Financial Officer at INVO Bioscience, a 205% increase compared to previous year.

Compensation breakdown

Option Awards$317,737
Salary$48,125
Total$365,862

Bowdring received $317.7K in option awards, accounting for 87% of the total pay in 2019.

Bowdring also received $48.1K in salary.

Rankings

In 2019, Robert Bowdring's compensation ranked 12,543rd out of 13,971 executives tracked by ExecPay. In other words, Bowdring earned more than 10.2% of executives.

ClassificationRankingPercentile
All
12,543
out of 13,971
10th
Division
Manufacturing
5,060
out of 5,692
11th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
716
out of 832
14th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
462
out of 535
14th
Industry
Surgical and Medical Instruments and Apparatus
305
out of 350
13th
Source: SEC filing on November 20, 2020.

Bowdring's colleagues

We found five more compensation records of executives who worked with Robert Bowdring at INVO Bioscience in 2019.

2019

Steven Shum

INVO Bioscience

Chief Executive Officer

2019

Kathleen Karloff

INVO Bioscience

Chief Executive Officer

2019

Michael Campbell

INVO Bioscience

Chief Operating Officer

2019

Lori Marzilli-Kahler

INVO Bioscience

Former VP, Global Operations

2019

Debra Hoopes

INVO Bioscience

Chief Financial Officer

News

In-depth

You may also like